Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo

S. 150, Affordable Prescriptions for Patients Act of 2023 (CBO Report for Congress)

Premium   Download PDF Now (10 pages)
Congress 118th
Date Requested March 1, 2023
Requested By the Senate Committee on the Judiciary
Date Sent June 13, 2024
Description:
S. 150 would amend the Federal Trade Commission Act to prohibit “product hopping.” Under the bill, a manufacturer of an original drug or biological product (that is, not a generic drug or a biosimilar biological product) would be considered to have engaged in product hopping if it marketed a reformulation or other follow-on product to treat the same or substantively similar condition and withdrew, discontinued, or otherwise unfairly placed the original product at a competitive disadvantage to the follow-on product.

« Return to search CBO reports